Literature DB >> 10752677

Cyclin D1 overexpression in a model of human breast premalignancy: preferential stimulation of anchorage-independent but not anchorage-dependent growth is associated with increased cdk2 activity.

Q Zhou1, J Wulfkuhle, T Ouatas, P Fukushima, M Stetler-Stevenson, F R Miller, P S Steeg.   

Abstract

Cyclin D1 is frequently overexpressed in human breast ductal carcinoma in situ (DCIS) specimens, which confer a high risk for the development of infiltrating ductal carcinoma. If causally involved in the genesis of human breast malignancy, cyclin D1 may represent an interesting target for chemopreventive approaches, as it sits at the junction of many growth factor and hormonal pathways. We have used the MCF-10A human breast cell line, derived from a mastectomy containing a low risk premalignant lesion, as a model system. Three cyclin D1 transfectants exhibited physiologically relevant levels of transgene overexpression, but no coordinate overexpression of other cell cycle related genes. Proliferation assays, flow cytometry, and cdk enzymatic assays of anchorage-dependent proliferation indicated only a minimal and transient effect of cyclin D1. In contrast, cyclin D1 overexpression significantly stimulated anchorage-independent colonization in soft agar or methylcellulose, accompanied by greater Gl-S progression. The cdk4 activity of the control- and cyclin D1 transfectants in colonization assays was comparable, but the cdk2 activity was higher in the latter. Injection of control- and cyclin D1 transfected MCF-10A cells in matrigel into nude mice failed to produce tumors within 1.5 years. The data suggest that cyclin D1 overexpression is an early feature of breast neoplastic progression, and can contribute to cancer development through the promotion of colonization.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10752677     DOI: 10.1023/a:1006370603147

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  5 in total

1.  AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer.

Authors:  Jose V Moyano; Joseph R Evans; Feng Chen; Meiling Lu; Michael E Werner; Fruma Yehiely; Leslie K Diaz; Dmitry Turbin; Gamze Karaca; Elizabeth Wiley; Torsten O Nielsen; Charles M Perou; Vincent L Cryns
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

2.  Is the small heat shock protein alphaB-crystallin an oncogene?

Authors:  Sofia K Gruvberger-Saal; Ramon Parsons
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

3.  Misregulation of gene expression in primary fibroblasts lacking poly(ADP-ribose) polymerase.

Authors:  C M Simbulan-Rosenthal; D H Ly; D S Rosenthal; G Konopka; R Luo; Z Q Wang; P G Schultz; M E Smulson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

4.  CyclinD1 protein plays different roles in modulating chemoresponses in MCF7 and MDA-MB231 cells.

Authors:  Yuan Sun; Dianzhong Luo; D Joshua Liao
Journal:  J Carcinog       Date:  2012-08-30

5.  Expression of two non-mutated genetic elements is sufficient to stimulate oncogenic transformation of human mammary epithelial cells.

Authors:  Vijay Pandey; Min Zhang; Mingliang You; Weijie Zhang; Rumei Chen; Wei Zhang; Lan Ma; Zheng-Sheng Wu; Tao Zhu; Xiu Qin Xu; Peter E Lobie
Journal:  Cell Death Dis       Date:  2018-11-19       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.